Colgate-Palmolive has risen more than 16% this year while also increasing its dividend.

Colgate-Palmolive (CL) is back in focus after recent share price moves and fresh performance data, giving investors a chance to reassess the consumer staples stock’s resilience and current valuation.

Is CL a good stock to buy? We came across a bullish thesis on Colgate-Palmolive Company on Compounding Dividends’s Substack.

Perspective is essential when investing. For example, market participants who are scoping out consumer packaged goods stocks as potential rebound opportunities for 2026 may be on to something, because ...

CL stock's strength reflects solid momentum, but inflation, North America softness and a premium valuation could keep new ...

Colgate-Palmolive Company CL has experienced a 7.3% decrease in its share price over the past month, a notable drop that was amplified following the release of its first-quarter fiscal 2025 results.

Colgate-Palmolive is a Dividend King with a 62-year record of dividend growth and global dominance in oral care products. CL recently rebounded from a multi-year earnings decline, driven by its 2022 ...

With consumer staples stocks out of favor, Colgate-Palmolive's share price slumped in 2025. The company has accelerated its product development pace. Colgate-Palmolive has met or exceeded its organic ...

A 15% year-to-date loss at a time when broader benchmarks are flirting with all-time highs may be enough to cause some investors to write off Colgate-Palmolive, but there are some sparks that could ...